CYCLOSPORIN IN THERAPEUTIC DOSES INCREASES RENAL ALLOGRAFT VASCULAR RESISTANCE
- 1 August 1986
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 328 (8505), 477-479
- https://doi.org/10.1016/s0140-6736(86)90355-7
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Intravenous cyclosporine activates afferent and efferent renal nerves and causes sodium retention in innervated kidneys in rats.Proceedings of the National Academy of Sciences, 1985
- REVERSIBILITY OF CYCLOSPORIN NEPHROTOXICITY AFTER THREE MONTHS' TREATMENTThe Lancet, 1985
- Chronic Irreversible Nephrotoxicity from Cyclosporin ANephron, 1985
- THE EFFECT OF SALT INTAKE ON CYCLOSPORINE-INDUCED IMPAIRMENT OF RENAL FUNCTION IN RATSTransplantation, 1984
- Cyclosporine-Associated Chronic NephropathyNew England Journal of Medicine, 1984
- CYCLOSPORIN IN CADAVERIC RENAL TRANSPLANTATION: ONE-YEAR FOLLOW-UP OF A MULTICENTRE TRIALThe Lancet, 1983
- A Randomized Clinical Trial of Cyclosporine in Cadaveric Renal TransplantationNew England Journal of Medicine, 1983
- EFFECT OF CYCLOSPORIN ON RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEMThe Lancet, 1982
- Quantitation of renal function with glomerular and tubular agentsSeminars in Nuclear Medicine, 1982
- Neural Degeneration and Regeneration in Human Renal TransplantsNew England Journal of Medicine, 1970